These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37726758)

  • 21. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
    Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonatal Preterm Respiratory Care in Ukraine: An Observational Study of Outcomes in Relation to Timing and Methods of Surfactant Treatment.
    Dobryanskyy DO; Menshykova AO; Salabay ZV; Detsyk OY
    Am J Perinatol; 2022 Jun; 39(8):889-896. PubMed ID: 33152767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.
    Minocchieri S; Berry CA; Pillow JJ;
    Arch Dis Child Fetal Neonatal Ed; 2019 May; 104(3):F313-F319. PubMed ID: 30049729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol for a randomised controlled trial comparing two CPAP levels to prevent extubation failure in extremely preterm infants.
    Kidman AM; Manley BJ; Boland RA; Malhotra A; Donath SM; Davis PG; Bhatia R
    BMJ Open; 2021 Jun; 11(6):e045897. PubMed ID: 34162644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
    JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
    BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Rojas-Reyes MX; Morley CJ; Soll R
    Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Sivakaanthan A; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002975. PubMed ID: 33058139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial in preterm infants comparing prophylactic with selective "less invasive surfactant administration" (pro.LISA).
    Göpel W; Rausch TK; Mitschdörfer B; Mader S; Herting E; König IR; Stichtenoth G;
    Trials; 2023 Sep; 24(1):612. PubMed ID: 37752593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial.
    Zhou R; Xiong T; Tang J; Huang Y; Liu W; Zhu J; Chen C; Gong L; Tian K; Wang A; Mu D
    Trials; 2023 Oct; 24(1):647. PubMed ID: 37803402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.
    Dell'Orto V; Nobile S; Correani A; Marchionni P; Giretti I; Rondina C; Burattini I; Palazzi ML; Carnielli VP
    Pediatr Pulmonol; 2021 Dec; 56(12):3879-3886. PubMed ID: 34610212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
    Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
    JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.